Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.27 INR | +3.58% | -4.20% | +6.05% |
Valuation
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 110 | 100.8 | 82.81 | 103.8 | 394.4 | 144.8 |
Enterprise Value (EV) 1 | 647.9 | 368.3 | 368 | 323.1 | 612.2 | 453.5 |
P/E ratio | 6.85 x | 8.79 x | 24.6 x | 26.4 x | 4.21 x | 20.5 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.06 x | 0.05 x | 0.05 x | 0.07 x | 0.27 x | 0.1 x |
EV / Revenue | 0.33 x | 0.19 x | 0.24 x | 0.22 x | 0.42 x | 0.32 x |
EV / EBITDA | 10.1 x | 5.99 x | 8.14 x | 10.5 x | 4.31 x | 14.6 x |
EV / FCF | -1.56 x | 1.48 x | -19.5 x | 4.49 x | 29.4 x | -5.23 x |
FCF Yield | -64% | 67.8% | -5.12% | 22.3% | 3.4% | -19.1% |
Price to Book | 0.32 x | 0.28 x | 0.23 x | 0.29 x | 0.87 x | 0.31 x |
Nbr of stocks (in thousands) | 3,747 | 3,747 | 3,747 | 3,747 | 3,747 | 3,747 |
Reference price 2 | 29.35 | 26.90 | 22.10 | 27.70 | 105.2 | 38.65 |
Announcement Date | 18-08-23 | 19-08-27 | 20-09-02 | 21-09-01 | 22-08-31 | 23-09-05 |
Income Statement Evolution (Annual data)
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 1,955 | 1,907 | 1,541 | 1,462 | 1,447 | 1,436 |
EBITDA 1 | 64.24 | 61.48 | 45.21 | 30.85 | 142 | 31 |
EBIT 1 | 58.25 | 54.97 | 38.89 | 26.83 | 138 | 26.77 |
Operating Margin | 2.98% | 2.88% | 2.52% | 1.83% | 9.54% | 1.86% |
Earnings before Tax (EBT) 1 | 17.83 | 13.53 | 3.241 | 9.778 | 129.6 | 10.13 |
Net income 1 | 16.06 | 11.47 | 3.389 | 3.935 | 93.62 | 7.078 |
Net margin | 0.82% | 0.6% | 0.22% | 0.27% | 6.47% | 0.49% |
EPS 2 | 4.285 | 3.060 | 0.9000 | 1.050 | 24.99 | 1.889 |
Free Cash Flow 1 | -415 | 249.6 | -18.84 | 72.02 | 20.82 | -86.65 |
FCF margin | -21.22% | 13.09% | -1.22% | 4.93% | 1.44% | -6.03% |
FCF Conversion (EBITDA) | - | 406.04% | - | 233.45% | 14.67% | - |
FCF Conversion (Net income) | - | 2,177.07% | - | 1,830.35% | 22.24% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 18-08-23 | 19-08-27 | 20-09-02 | 21-09-01 | 22-08-31 | 23-09-05 |
Balance Sheet Analysis
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 538 | 268 | 285 | 219 | 218 | 309 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 8.374 x | 4.352 x | 6.308 x | 7.11 x | 1.534 x | 9.958 x |
Free Cash Flow 1 | -415 | 250 | -18.8 | 72 | 20.8 | -86.6 |
ROE (net income / shareholders' equity) | 4.79% | 3.29% | 0.95% | 1.1% | 23% | 1.54% |
ROA (Net income/ Total Assets) | 4.25% | 3.86% | 3.4% | 2.41% | 12% | 2.03% |
Assets 1 | 377.9 | 297.4 | 99.71 | 163.4 | 782.9 | 348.8 |
Book Value Per Share 2 | 91.60 | 94.40 | 95.10 | 96.30 | 121.0 | 123.0 |
Cash Flow per Share 2 | 1.030 | 11.00 | 6.250 | 0.6500 | 12.90 | 6.390 |
Capex 1 | 0.03 | 4.77 | 1.56 | 0.01 | 18.6 | 21.4 |
Capex / Sales | 0% | 0.25% | 0.1% | 0% | 1.28% | 1.49% |
Announcement Date | 18-08-23 | 19-08-27 | 20-09-02 | 21-09-01 | 22-08-31 | 23-09-05 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+6.05% | 2.08M | |
+0.52% | 287B | |
-6.38% | 90.96B | |
-7.00% | 41.76B | |
+2.28% | 41.74B | |
+5.16% | 39.65B | |
+3.56% | 38.08B | |
-15.16% | 30.29B | |
-5.86% | 28.91B | |
+8.15% | 24.27B |
- Stock Market
- Equities
- NATRAJPR6 Stock
- Financials Natraj Proteins Limited